Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine + propofol versus methohexital anesthesia for electroconvulsive therapy
2021-003676-13Phase 4Active
- Sponsor
- Medical University of Vienna
- Start
- Jun 2022
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD) and bipolar disorder (BD) comparing Esketamine + propofol anesthesia with Methohexital anesthesia (2 arms). Primary endpoint: HAMD-17 score after ECT course. Started Jun 2022; status: active.
02
Drugs
esketaminepropofolmethohexital
03
Conditions
major depressive disorder (MDD)bipolar disorder (BD)
Beyond the preview
Go deeper on 2021-003676-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-003676-13.